6[1]Cervera R,Khamashta MA,Font J,et al.Morbidity and mortality in systemic lupus erythematosus during a 5-year period.A multicenter prospective study of 1 000 patients.European Working Party on Systemic Lupus Erythematosus[J].Medicine,1999,78(3): 167-175.
7[2]Mok CC,Lee KW,Ho CT,et al.A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population[J].Rheumatology (Oxford),2000,39(4): 399-406.
8[3]Juarez M,Misischia R,Alarcon GS.Infections in systemic connective tissue diseases: systemic lupus erythematosus,scleroderma,and polymyositis/dermatomyositis[J].Rheum Dis Clin North Am,2003,29(1): 163-84.
9[4]Leone M,Bourgoin A,Cambon S,et al.Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome[J].Crit Care Med,2003,31(2): 462-467.
10[5]Gladman DD,Hussain F,Ibanez D,et al.The nature and outcome of infection in systemic lupus erythematosus[J].Lupus,2002,11(4): 234-239.
6Santos Ocampo A S, Mandell B F, Fessler B J. Alveolar Hemorrhage in Systemic Lupus ErythematosusPresentation and Management [ J ]. CHEST Journal, 2000, 118 ( 4 ) : 1083.
7Todd D J, Costenbader K H. Dyspnoea in a young woman with active systemic lupus erythematosus[J ]. Lupus, 2009, 18(9): 777.
